PT  - JOURNAL ARTICLE
AU  - Alasdair Bamford
AU  - Gareth Tudor-Williams
AU  - Caroline Foster
TI  - Post-exposure prophylaxis guidelines for children and adolescents potentially exposed to HIV
AID  - 10.1136/archdischild-2015-309297
DP  - 2017 Jan 01
TA  - Archives of Disease in Childhood
PG  - 78--83
VI  - 102
IP  - 1
4099  - http://adc.bmj.com/content/102/1/78.short
4100  - http://adc.bmj.com/content/102/1/78.full
SO  - Arch Dis Child2017 Jan 01; 102
AB  - UK guidelines for HIV post-exposure prophylaxis (PEP) in adults have recently been updated. Indications for PEP have been modified and there has been a change in the recommended antiretroviral therapy for adults to a combination of raltegravir with tenofovir and emtricitabine (Truvada). Raltegravir and tenofovir are now available in paediatric formulations and offer improved safety and tolerability over previously recommended ritonavir-boosted lopinavir with zidovudine. This guideline provides recommendations for those caring for children potentially exposed to HIV and other bloodborne viruses in primary care, emergency departments, secondary care and specialist paediatric HIV centres.